Heart & Stroke
Paul Salvaterra is a seasoned professional in emergency resuscitation and training, currently serving as the Core Resuscitation Products Manager at Heart & Stroke since January 2022. In this role, Paul oversees the development and implementation of innovative CPR and AED programs for diverse organizations. Previously, Paul held the position of Director at Chiron Training from June 2014 to March 2021, where responsibilities included course design, evaluation, and conducting essential safety training for national and international clients. Paul also served as a Senior Project Specialist for the AED Program at Heart & Stroke from January 2012 to June 2014, where skills were demonstrated by successfully managing Canada's largest Public Access Defibrillation program, significantly exceeding training and installation targets. Earlier in Paul’s career, experience as an Education Coordinator at Cardiac Science included implementing the world’s largest public access defibrillation program. Paul holds a Bachelor’s Degree in English from California State University, Los Angeles.
Heart & Stroke
1 followers
For over 70 years, Heart & Stroke has been at the forefront of tackling pressing issues related to heart disease, stroke and vascular cognitive impairment. We drive life-saving medical breakthroughs and act as a catalyst to bring together the brightest minds to improve diagnosis, care and support. Our work has saved thousands of lives and improved millions of others. Since 1952, we have invested more than $1.65 billion into supporting best-in-class researchers as they work to discover revolutionary medical advances. In that time, the death rate from heart disease and stroke in Canada has declined by over 75%. Working together, our employees, volunteers, researchers, partners, people with lived experience and their families, and donors have made us what we are today: Canada’s most trusted authority on heart and brain health. Together, we will beat heart disease and stroke. *** Depuis plus de 70 ans, Cœur + AVC joue un rôle de premier plan dans la lutte contre les maladies du cœur, l’AVC et les déficits cognitifs d’origine vasculaire. Nous facilitons des découvertes médicales qui sauvent des vies et rassemblons les plus grands esprits scientifiques afin d’améliorer le diagnostic, les soins et le soutien. Notre travail a permis de sauver des milliers de vies et d’en améliorer des millions d’autres. Depuis 1952, nous avons investi plus de 1,65 milliard de dollars dans la recherche en soutenant des scientifiques émérites qui travaillent à réaliser des avancées médicales révolutionnaires. Au cours de cette période, les taux de décès liés aux maladies du cœur et à l’AVC au pays ont chuté de plus de 75 %. En travaillant ensemble, notre personnel, nos bénévoles, nos scientifiques, nos partenaires, nos donateurs, les personnes ayant une expérience vécue et leurs familles nous ont permis de devenir qui nous sommes aujourd’hui : l’autorité la plus reconnue au pays en matière de santé cardiaque et cérébrale. Ensemble, nous combattrons les maladies du cœur et l’AVC.